Ascelia Pharma: Good US Orviglance news - Redeye
Bildkälla: Stockfoto

Ascelia Pharma: Good US Orviglance news - Redeye

Ascelia is progressing with the Orviglance application, and the company is about to complete the electronic configuration of the file. A submission is due by the end of August or early September.

Ascelia is progressing with the Orviglance application, and the company is about to complete the electronic configuration of the file. A submission is due by the end of August or early September.
Börsvärldens nyhetsbrev